Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies
Description
Despite widespread vaccination rates, we are living with high transmission rates of SARS-CoV-2. Although overall hospitalisation rates are falling, the risk of serious infection remains high for patients who are immunocompromised because of
